Investors

Shareholders Information

The Company's ordinary shares are listed and trade on the London Stock Exchange AIM market.

Shares in issue 
23,820,863,756 Ordinary Shares of 0.01p each.
There are no restrictions on the transfer of the company's securities

Significant & Directors' Shareholdings

https://www.ambienpharmacy.org/

Designation Shareholder Name Amount % Holding
15942 HARGREAVES LANSDOWN (NOMINEES) LIMITED 3,353,593,919 14%
SMKTNOMS INTERACTIVE INVESTOR SERVICES NOMINEES LIMITED 2,166,793,380 9%
VRA HARGREAVES LANSDOWN (NOMINEES) LIMITED 1,820,232,426 8%
CLIENT1  BARCLAYS DIRECT INVESTING NOMINEES LIMITED 1,722,901,861 7%
HLNOM HARGREAVES LANSDOWN (NOMINEES) LIMITED 1,687,946,387 7%
JARVIS JIM NOMINEES LIMITED 1,653,345,812 7%
SMKTISAS INTERACTIVE INVESTOR SERVICES NOMINEES LIMITED 1,511,674,810 6%
  HSDL NOMINEES LIMITED 1,286,403,212 6%
MAXI HSDL NOMINEES LIMITED 1,051,480,809 5%
731504 HSBC CLIENT HOLDINGS NOMINEE (UK) LIMITED 870,645,049 4%
IGUKCLT VIDACOS NOMINEES LIMITED 781,077,887 3%
       


The total percentage of shares not in public hands is 0.07% defined as being beneficial holdings of shares held by shareholders holding above 10% and the directors holdings.


Last updated: 9 November 2023